Skip to main content

Advertisement

Fig. 5 | Journal of Experimental & Clinical Cancer Research

Fig. 5

From: Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells

Fig. 5

Gal1-mediated upregulation of RER1 promotes HCC migration and invasion. a. Heat map revealed expressions of protein candidates with at least 2-fold difference between non-target control (shCtrl) and Gal-1 knockdown cells (shGal1#1). b. Top ten listed genes downregulated in Gal-1 knockdown cells when compared to control cells. A ratio with less than 0.5 represents a more than 2-fold downregulation in shGal1 cells. c. Quantitative PCR analysis of RER1 expression in the control and Gal-1 knockdown cells. d. RER1 expression was rescued in Gal-1 knockdown cells by transfecting an expression vector of RER1 into shGal1#1. Quantitative PCR revealed the upregulation of RER1 in Gal-1 knockdown cells. e. Migration (left) and invasion (right) assays were performed using RER1-transfected Gal-1 knockdown cells. f. Expression of RER1 in 50 cases of paired HCC tumorous and non-tumorous tissues of TCGA database was compared. g. A positive correlation between Gal-1 and RER1 expressions was found in HCC cases obtained from TCGA database. P < 0.05 is considered statistically significant

Back to article page